CoChat

My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed

Open access
Martelletti, Paolo, Schwedt, Todd J., Lanteri-Minet, Michel, Quintana, Rebeca, Carboni, Veruska, Diener, Hans-Christoph, Ruiz de la Torre, Elena, Craven, Audrey, Rasmussen, Annette Vangaa, Evans, Simon, Laflamme, Annik K., Fink, Rachel, Walsh, Donna, Dumas, Paula, Vo, Pamela · 2018 · The Journal of Headache and Pain

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index; 11 of the 22 sources its claims cite were checked for support.

Abstract

BACKGROUND: Migraine is associated with many debilitating symptoms that affect daily functioning. My Migraine Voice is a large global cross-sectional study aimed at understanding the full burden and impact of migraine directly from patients suffering from ≥4 monthly migraine days (MMDs) with a history of prophylactic treatment failure. METHODS: This study was conducted worldwide (31 countries across North and South Americas, Europe, the Middle East and Northern Africa, and the Asia-Pacific region) using an online survey administered to adults with migraine who reported ≥4 MMDs in the 3 months preceding survey administration, with pre-specified criteria of 90% having used preventive migraine treatment (80% with history of ≥1 treatment failure). Prophylactic treatment failure was defined as a reported change in preventive medication by individuals with migraine for any reason, at least once. RESULTS: In total, 11,266 individuals participated in the survey. Seventy-four percent of the participants reported spending time in darkness/isolation due to migraine (average: 19 h/month). While 85% of all respondents reported negative aspects of living with migraine (feeling helpless, depressed, not understood), sleeping difficulties (83%), and fear of the next attack (55%), 57% shared ≥1 positive aspect (learning to cope, becoming a stronger person). Forty-nine percent reported feeling limited in daily activities throughout all migraine phases. Migraine impact on professional, private, or social domains was reported by 87% of respondents (51% in all domains). In the previous 12 months, 38% of respondents had visited the emergency department (average: 3.3 visits), whereas 23% stayed in hospital overnight (average: 3.2 nights) due to migraine. CONCLUSIONS: The burden of migraine is substantial among this cohort of individuals with at least 4 migraine days per month and for whom at least 1 preventive migraine treatment had failed. Interestingly, respondents reported some positive aspects in their migraine journey; the greater resilience and strength brought on by coping with migraine suggests that if future treatments could address existing unmet needs, these individuals with migraine will be able to maximize their contribution to society.

Overview

CoChat Summary

## TL;DR

My Migraine Voice was a 31-country online cross-sectional survey of 11,266 adults with migraine and at least 4 monthly migraine days, designed to measure the burden of migraine, especially among people with prior preventive treatment failure. The study found substantial personal, social, work, and healthcare burden, including 74% spending time in darkness/isolation, 87% reporting impact on professional/private/social domains, and 38% visiting the emergency department in the prior 12 months.

## Key findings

  • Among 11,266 participants, 74% reported spending time in darkness/isolation due to migraine, averaging 19 h/month; 83% reported sleeping difficulties and 55% feared the next attack.
  • Migraine affected professional, private, or social domains in 87% of respondents, and 51% reported impact in all three domains.
  • In the previous 12 months, 38% visited the emergency department for migraine (average 3.3 visits) and 23% stayed in hospital overnight (average 3.2 nights).
  • Work burden was substantial: among employed respondents, migraine led to 13% reduction in working time and 48% impairment while working; 52% reported impairment in overall work productivity and daily activities.

## Methods

  • Large cross-sectional, multi-country online survey of adults (≥18 years) with migraine in 31 countries across the Americas, Europe, the Middle East and Northern Africa, and Asia-Pacific.
  • Eligibility required self-reported migraine with ≥4 monthly migraine days in the prior 3 months; prespecified quotas targeted prior preventive treatment exposure, with 90% reporting current or previous preventive use and 80% of those having switched preventive treatment; 11,266 people participated.
  • The survey contained 88 questions and assessed sociodemographics, migraine characteristics, quality of life, daily activities, treatment experience, healthcare use, and work productivity; analyses were descriptive with subgroup comparisons by treatment-failure history using frequencies, means/medians, SDs, t-tests, and chi-square tests.

## Limitations

  • The paper states that the sample does not fully mirror the general migraine population; recruitment bias may affect estimates, and people with 1–3 monthly migraine days, those without internet access, and those outside the recruitment catchment were not included.
  • The study relied on self-reported diagnoses, healthcare use, and other variables, so these could not be clinically confirmed.
  • The text indicates that pooling data across countries may introduce variability, and the cross-sectional design means no longitudinal follow-up; these are evident from the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s10194-018-0946-z

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 The My Migraine Voice Study Population Accrued per Applied Criteria. *Predetermined quotas
Fig. 1 The My Migraine Voice Study Population Accrued per Applied Criteria. *Predetermined quotasCC BY · PubMed Central

Verification

Claims the paper makes

3 Valid · 0 Not valid · 4 Not checked · 71 Own results and interpretations

23 more claims

Create a free account to see all 78 claims and to verify the 11 references still open.

See all claims — free account
  • It may state two separate claims as one. 42
  • Probably not a substantial claim. 16

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 11 references

Research works printed but not linked: 2

  1. Ruiz de la Torre E, Martelletti P, Craven A et al (2017) Real-world patient perspective on the burden and impact of migraine. Presented at: Congress of the International Headache Society, Vancouver; September 7–10, [Poster #PO-02-184]
  2. Ruiz de la Torre E, Martelletti P, Craven A et al (2017) Burden and impact of migraine: a caregiver’s perspective. Presented at: Congress of the International Headache Society, Vancouver September 7–10, [Poster #PO-02-185]

Cited by

See all 217

Metadata

Authors
Martelletti, P., Schwedt, T. J., Lanteri-Minet, M., Quintana, R., Carboni, V., Diener, H.-C., Ruiz de la Torre, E., Craven, A., Rasmussen, A. V., Evans, S., Laflamme, A. K., Fink, R., Walsh, D., Dumas, P., & Vo, P.
Affiliations
  • Sapienza University of Rome (IT)
  • Mayo Clinic (US)
  • University of Duisburg-Essen (DE)
  • Glostrup Hospital (DK)
  • Novartis (Switzerland) (CH)
Corresponding author
Schwedt, Todd J.
Venue
The Journal of Headache and Pain
Published
2018-11-27
Volume
19
Issue
1
Pages
115-115
ISSN
  • 1129-2369 (ISSN-L)
  • 1129-2377
OpenAlex
W2902418797
Cited by
217
References
11
Citations by year
2026: 12 · 2025: 17 · 2024: 38 · 2023: 26 · 2022: 32 · 2021: 35 · 2020: 43 · 2019: 13 · 2018: 1
FWCI
18.05
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • The Journal of Headache and Pain (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Novartis Pharma AG (N/A)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Clinical Neurology › Intracranial Aneurysms: Treatment and Complications
Keywords
migraine, disease burden, sleep disorders, emergency department visits, coping and resilience, patient experience, unmet needs
MeSH terms
Adult, Analgesics, Cross-Sectional Studies, Europe, Female, Humans, Male, Middle Aged, Migraine Disorders, Preventive Medicine, Surveys and Questionnaires, Global Health, Cohort Studies, Treatment Failure, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. https://app.cochat.ai/papers/10.1186/s10194-018-0946-z
The paper
Martelletti, P., Schwedt, T. J., Lanteri-Minet, M., Quintana, R., Carboni, V., Diener, H.-C., Ruiz de la Torre, E., Craven, A., Rasmussen, A. V., Evans, S., Laflamme, A. K., Fink, R., Walsh, D., Dumas, P., & Vo, P. (2018). My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-018-0946-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.